In addition to CCL17 and CCL22, CCL2 (monocyte-chemo-attractant protein 1, MCP-1) critically drives TAM formation [31,32], and its receptor CCR2 is involved in cancer progression [33,34,35]. Here, CCL2 is linked to cancer.